Gene: PBDC1
Official Full Name: polysaccharide biosynthesis domain containing 1provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22778 | PBDC1 Knockout cell line (HeLa) | Human | PBDC1 | 1:3~1:6 | Negative | Online Inquiry |
KO22779 | PBDC1 Knockout cell line (HCT 116) | Human | PBDC1 | 1:2~1:4 | Negative | Online Inquiry |
KO22780 | PBDC1 Knockout cell line (HEK293) | Human | PBDC1 | 1:3~1:6 | Negative | Online Inquiry |
KO22781 | PBDC1 Knockout cell line (A549) | Human | PBDC1 | 1:3~1:4 | Negative | Online Inquiry |
PBDC1 Gene Knockout Cell Lines are engineered cellular models designed to study the functional role of the PBDC1 gene, which is critical for various biological processes, including cell signaling and apoptosis. These cell lines are created through targeted gene editing techniques such as CRISPR-Cas9, enabling precise knockout of the PBDC1 gene, thus allowing researchers to investigate the resultant phenotypic changes and underlying molecular pathways involved.
The key function of PBDC1 Gene Knockout Cell Lines is to facilitate the exploration of gene function through loss-of-function experiments. By eliminating the expression of the PBDC1 gene, researchers can dissect its role in cellular proliferation, differentiation, and stress response mechanisms. Additionally, these cell lines serve as valuable tools in drug discovery and development, providing insights into how the absence of PBDC1 influences cell behavior and treatment responses.
The scientific importance of these knockout cell lines in research cannot be overstated. They enable a deeper understanding of genetic contributions to diseases, including cancer and neurodegenerative disorders. Clinically, the data generated from studies utilizing these cell lines can lead to the identification of novel therapeutic targets or biomarkers for disease susceptibility and progression.
One of the distinct advantages of the PBDC1 Gene Knockout Cell Lines is the high specificity and reproducibility offered by the CRISPR-Cas9 editing method. Unlike alternative models, which may provide less reliable data due to incomplete knockouts or heterogeneous cell populations, these engineered cell lines guarantee a uniform genetic background and consistent results, thus enhancing the validity of experimental findings.
For researchers and clinicians focused on genetic mechanisms, these cell lines represent a critical advancement in the toolkit of molecular biology. They open pathways to innovative research that can translate into impactful clinical applications. With our extensive experience in biological product development and a commitment to quality, we provide superior knockout cell lines that empower scientific discovery and advance therapeutic innovations.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.